Biotechnology company Phico Therapeutics has been awarded £1.4 million ($1.87 million USD) by Innovate UK for development of its intravenous antibiotic, SASPject PT3.8. This antibacterial therapy is for the systemic treatment of patients with serious Pseudomonas aeruginosa (P. aeruginosa) infect...
Aug 21 2018 Read 44 Times
In This Edition Articles - Why Does Nanotechnology Require Mass Spectrometry Spotlight Features Luminescence, UV & Microplate Readers - New Confocal Laser Scanning Microscope Combine...
View all digital editions
Aug 26 2018 Liverpool, UK
Aug 26 2018 Krakow, Poland
Aug 26 2018 Florence, Italy
Aug 29 2018 Singapore
Sep 05 2018 Phnom Penh, Cambodia